Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary hepatic lymphoma.

C S Chim1, C Choy, G C Ooi

  • 1University Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong. jcschim@hkucc.hku.hk

Leukemia & Lymphoma
|June 28, 2001
PubMed
Summary
This summary is machine-generated.

Primary Burkitt's lymphoma of the liver presented as a large abdominal mass. Despite responding to chemotherapy, the patient succumbed to neutropenic sepsis.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomized Phase 3 study of pomalidomide cyclophosphamide dexamethasone versus pomalidomide dexamethasone in relapse or refractory myeloma: an Asian Myeloma Network study (AMN003).

Blood cancer journal·2025
Same author

Foot care knowledge and self-care practices among diabetic patients in Penang: A primary care study.

The Medical journal of Malaysia·2022
Same author

The functional role of surface molecules on extracellular vesicles in cancer, autoimmune diseases, and coagulopathy.

Journal of leukocyte biology·2020
Same author

Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond.

Leukemia·2019
Same author

Multiple myeloma in patients up to 30 years of age: a multicenter retrospective study of 52 cases.

Leukemia & lymphoma·2018
Same author

Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond.

Leukemia·2017
Same journal

CPX‑351 vs. FLAG‑ida in patients with high-risk AML/MDS and MDS-related gene mutations: a subgroup analysis of the UK NCRI AML19 trial.

Leukemia & lymphoma·2026
Same journal

Specialist palliative care access and end-of-life hospitalizations in acute leukemia: a nationwide register study.

Leukemia & lymphoma·2026
Same journal

D-VRD vs. D-KRD induction in transplant-eligible multiple myeloma: a real-world comparison.

Leukemia & lymphoma·2026
Same journal

T-box factor EOMES is part of an aberrant network in Hodgkin lymphoma.

Leukemia & lymphoma·2026
Same journal

Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general population.

Leukemia & lymphoma·2026
Same journal

Hypertension and time to treatment failure with acalabrutinib and ibrutinib in treatment-naïve CLL/SLL.

Leukemia & lymphoma·2026
See all related articles

Area of Science:

  • Hepatobiliary Malignancies
  • Oncology
  • Abdominal Imaging

Background:

  • Burkitt's lymphoma is an aggressive non-Hodgkin lymphoma.
  • Primary hepatic involvement is rare.

Observation:

  • A patient presented with a massive, painless abdominal mass.
  • Computed tomography (CT) imaging revealed the extent of the tumor.

Findings:

  • Histologic examination confirmed primary Burkitt's lymphoma of the liver.
  • The tumor demonstrated initial response to chemotherapy.

Implications:

  • This case highlights the rare presentation of primary liver Burkitt's lymphoma.
  • Neutropenic sepsis remains a significant risk in lymphoma treatment.